← Back to Search

Narrative breast health education for Screening Mammogram

N/A
Waitlist Available
Led By Lina Jandorf
Research Sponsored by Icahn School of Medicine at Mount Sinai
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months post intervention
Awards & highlights

Study Summary

This trial is looking at how to better screen Chinese immigrants for breast cancer in NYC by developing and testing a culturally- and linguistically-adapted program. They will be conducting interviews to assess breast cancer knowledge and barriers to screenings before testing the program with 96 women.

Eligible Conditions
  • Screening Mammogram

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months post intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months post intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Screening mammogram completion
Secondary outcome measures
Change in Feasibility and Acceptability Questionnaire
Screening mammogram intention

Trial Design

1Treatment groups
Experimental Treatment
Group I: Chinese ImmigrantsExperimental Treatment1 Intervention
NYC Chinese immigrants provided with narrative breast health education
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Narrative breast health education
2021
N/A
~100

Find a Location

Who is running the clinical trial?

Icahn School of Medicine at Mount SinaiLead Sponsor
860 Previous Clinical Trials
524,377 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,660 Previous Clinical Trials
40,924,235 Total Patients Enrolled
Lina JandorfPrincipal InvestigatorIcahn School of Medicine at Mount Sinai

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research venture actively recruiting participants?

"The trial posted on July 1st 2021 has since ended its recruitment phase, according to information found on clinicaltrials.gov. However, a plethora of 2289 alternate medical studies are currently accepting participants for their testing and data collection phases."

Answered by AI
~26 spots leftby Apr 2025